# Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes

> **NCT04617795** · NA · COMPLETED · sponsor: **Insulet Corporation** · enrollment: 25 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DEVICE:** Omnipod 5 Automated Insulin Delivery System

## Key facts

- **NCT ID:** NCT04617795
- **Lead sponsor:** Insulet Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-23
- **Primary completion:** 2022-03-06
- **Final completion:** 2022-03-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04617795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04617795, "Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04617795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*